Pulmonary Embolism in Focus

Rüdiger E. Scharf

doi:10.1055/s-0038-1637770

Hämostaseologie, Table of Contents

Hamostaseologie 2018; 38(01): 07-08
DOI: 10.1055/s-0038-1637770

Editorial

Schattauer GmbH

Pulmonary Embolism in Focus

Authors

Rüdiger E. Scharf

¹Division of Experimental and Clinical Hemostasis, Hemotherapy and Transfusion Medicine, and Hemophilia Comprehensive Care Center, Institute of Transplantation Diagnostics and Cell Therapy, Heinrich Heine University Medical Center, Düsseldorf, Germany

References
1 Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis 2016; 41: 3-14.
2 Cohen AT, Agnelli G, Anderson FA. et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98: 756-764.
3 Heit JA, Silverstein MD, Mohr DN. et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86: 452-463.
4 Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol 2015; 12: 464-474.
5 Konstantinides SV, Barco S, Lankeit M, Meyer G. Management of pulmonary embolism: an update. J Am Coll Cardiol 2016; 67: 976-990.
6 Konstantinides SV, Torbicki A, Agnelli G. et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014 35. 3033-3069 69a-69k.
7 Konstantinides SV. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35: 3145-3146.
8 Konstantinides SV. Trends in pulmonary embolism outcomes: are we really making progress?. J Am Coll Cardiol 2016; 67: 171-173.
9 Scharf RE. Awareness and attraction or adhesion and activation. Hamostaseologie 2018; 38: 5-6.
10 Righini M, Robert-Ebadi H. Diagnosis of acute pulonary embolism. Hamostaseologie 2018; 38: 11-21.
11 Klok FA, Barco S. Follow-up after acute pulmonary embolism. Predicting chronic thromboembolic pulmonary hypertension and post-pulmonary embolism syndrome. Hamostaseologie 2018; 38: 22-32.
12 Bulato C, Campello E, Gavasso S, Maggiolo S, Tormene D, Simioni P. Peculiar laboratory phenotype/ genotype relationship due to compound inherited protein C defects in a child with severe venous thromboembolism. Hamostaseologie 2018; 38: 33-38.
13 Hajsmanová Z, Sigutová P, Lavicková A. Repeated administration of idarucizumab to a patient with dabigatran overdose. Hamostaseologie 2018; 38: 39-42.
14 Zhu L, Wang Y, Zhao M. et al. Novel mutations (gammaTrp208Leu and gammaLys232Thr) leading to congenital hypofibrinogenemia in two unrelated Chinese families. Blood Coagul Fibrinolysis 2014; 25: 894-897.
15 Zhao M, Wang M, Lou Z. et al. Congenital hypofibrinogenemia associated with gamma-K232T. In vitro expression demonstrates defective secretion of the variant fibrinogen. Hamostaseologie 2018; 38: 43-48.